Our biosynthetic production method uses yeast to deliver cannabinoids that are chemically identical to a number of the phytocannabinoids extracted from cannabis and hemp.

The cannabinoids produced this way are pure, environmentally sustainable, chemically consistent, and never contaminated by insecticides or organic materials.

Cannabis Plant

Leading the new frontier of patentable cannabinoid medicines.


We produce the following cannabinoids for the purpose of research and development:

  • CBC (Cannabichromene)
  • CBG (Cannabigerol)
  • CBT (Cannabitriol)
  • CBN (Cannabinol)
  • CBDA (Cannabidiolic acid)
  • CBGA (Cannabigerolic acid)
  • CBCA (Cannabichromene acid)
  • THCV (Δ9-Tetrahydrocannabivarin)
  • THCVA (Tetrahydrocannabivarinic acid), and
  • CBD (Cannabidiol)

All of the cannabinoids listed on our website are currently being studied for various possible therapeutic benefits.

The FDA has not evaluated these and other cannabinoids for these therapeutic benefits.

Are you or your company interested in cannabinoids for legal and accredited clinical research? Please don't hesitate to contact us to inquire about the availability and price of our biosynthetic cannabinoid products.

Our Facility

We have developed a 16,000 sq. ft. fully-licensed commercial batch facility in southern California, including:

Research Labs
A production facility for laboratory scale and pilot production runs.
Advanced bioreactor systems production facility with off-gas analysis and coupling to analytical equipment (HPLC, LC-MS) for streamlined process development and cost-effective fermentations.
An extensive suite of micro-scale, bench-top and large-scale bioreactor systems to optimize the production of a broad range of fermentation-based production applications.

We're Looking For Partners.

Is that you?